GMPS - guanine monophosphate synthase Gene
Species: Bos taurus
Gene Type: protein coding
Gene ID: 511200
GMPS Products (2)
| mRNA | Protein | Name |
|---|---|---|
| NM_001206436.1 | NP_001193365.1 | GMP synthase [glutamine-hydrolyzing] |
| NM_001206436.1 | NP_001193365.1 | GMP synthase [glutamine-hydrolyzing] |
| Protein Preferred Names | Protein Names | |
|---|---|---|
|
GMP synthase [glutamine-hydrolyzing] |
|
Related Agents
- Approval
- Clinical Phase
- Pre-clinical Phase
Approval
Bioactive Molecules
(1)
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-B1730 | Phensuximide | 99.41% | Unkown |
Clinical Phase
Bioactive Molecules
(12)
| Cat. No. | Product Name |
Effect
|
Purity |
Phase |
|---|---|---|---|---|
| HY-101952G | Prostaglandin E2 (GMP) | / | Phase 4 | |
| HY-18085G | Quercetin (GMP) | / | Phase 4 | |
| HY-B0166GL | L-Ascorbic acid (GMP Like) | 99.88% | Phase 4 | |
| HY-50895G | Gefitinib (GMP) | / | Phase 4 | |
| HY-15233G | Letermovir (GMP) | Inhibitor | / | Phase 4 |
| HY-14649G | Retinoic acid (GMP) | Agonist | / | Phase 3 |
| HY-19980G | Eprenetapopt (GMP) | / | Phase 3 | |
| HY-13740G | Resiquimod (GMP) | Agonist | / | Phase 2 |
| HY-10254G | Mirdametinib (GMP) | Inhibitor | / | Phase 2 |
| HY-B0166G | L-Ascorbic acid (GMP) | / | Phase 2 | |
| HY-17500 | Ataciguat | Activator | 99.70% | Phase 2 |
| HY-100164 | SDZ-MKS 492 | Inhibitor | 99.77% | Phase 1 |
Pre-clinical Phase
Bioactive Molecules
(288)
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-10182 | Laduviglusib | 99.76% | Unkown | |
| HY-114180 | RU.521 | Inhibitor | 99.95% | Unkown |
| HY-100564 | 2',3'-cGAMP | Activator | 99.95% | Unkown |
| HY-100564A | 2',3'-cGAMP sodium | Activator | 99.89% | Unkown |
| HY-12512 | cGAMP | Activator | 99.22% | Unkown |
| HY-136769 | Biotin-HPDP | 99.73% | Unkown | |
| HY-133916 | G140 | Inhibitor | 99.17% | Unkown |
| HY-10583G | Y-27632 dihydrochloride (GMP) | Inhibitor | / | Unkown |
| HY-10182G | Laduviglusib (GMP) | / | Unkown | |
| HY-128583 | G150 | Inhibitor | 99.20% | Unkown |
| HY-110382 | Cyclic-di-GMP disodium | Activator | 98.78% | Unkown |
| HY-10431G | SB-431542 (GMP) | Inhibitor | / | Unkown |
| HY-110385 | cGAMP disodium | Activator | 98.47% | Unkown |
| HY-111673 | 8-CPT-Cyclic AMP sodium | 99.92% | Unkown | |
| HY-113469 | Cyclic GMP | 99.77% | Unkown | |
| HY-15575G | VcMMAE (GMP) | / | Unkown | |
| HY-13631AG | Exatecan mesylate (GMP) | Inhibitor | / | Unkown |
| HY-13012G | RepSox (GMP) | Inhibitor | / | Unkown |
| HY-114182 | PF-06928215 | Inhibitor | 99.68% | Unkown |
| HY-107413 | SR11237 | 99.99% | Unkown | |
| HY-107780B | Cyclic-di-GMP diammonium | Activator | 99.07% | Unkown |
| HY-101835 | Decoyinine | Inhibitor | 99.96% | Unkown |
| HY-137662 | 5'-Phosphoguanylyl-(3',5')-guanosine | Control | 95.77% | Unkown |
| HY-10182R | Laduviglusib (Standard) | 99.52% | Unkown | |
| HY-113469A | Cyclic GMP sodium | 99.89% | Unkown | |
| HY-12071G | LDN193189 (GMP) | Inhibitor | / | Unkown |
| HY-13027G | DAPT (GMP) | Inhibitor | / | Unkown |
| HY-15162G | Monomethyl auristatin E (GMP) | / | Unkown | |
| HY-12379 | NS-2028 | Inhibitor | 99.58% | Unkown |
| HY-10432G | A 83-01 (GMP) | Inhibitor | / | Unkown |
| HY-13257G | Thiazovivin (GMP) | Inhibitor | / | Unkown |
| HY-107202GL | Polyinosinic-polycytidylic acid (GMP Like) | 90.5% | Unkown | |
| HY-160546 | cGAS-IN-2 | Inhibitor | 99.67% | Unkown |
| HY-B0445GL | NAD+ (GMP Like) | 99.79% | Unkown | |
| HY-149526 | cGAS-IN-1 | Inhibitor | 98.21% | Unkown |
| HY-P0229 | Ribonuclease T1, Aspergillus oryzae | / | Unkown | |
| HY-15108G | Purmorphamine (GMP) | Agonist | / | Unkown |
| HY-114181 | IRAK4-IN-4 | Inhibitor | 99.55% | Unkown |
| HY-15001G | Stemregenin 1 (GMP) | Antagonist | / | Unkown |
| HY-170362 | cGAS-IN-4 | Inhibitor | 99.28% | Unkown |
| HY-A0070AG | Liothyronine (GMP) | Agonist | / | Unkown |
| HY-N1938 | D(+)-Raffinose pentahydrate | 98.0% | Unkown | |
| HY-P5979 | LRRKtide | Substrate | 99.94% | Unkown |
| HY-W010759 | Inosine-5′-monophosphate disodium salt octahydrate | 98.0% | Unkown | |
| HY-W013111 | 2′-Deoxy-GDP trisodium | Inhibitor | 98.78% | Unkown |
| HY-124700 | LYPLAL1-IN-1 | 99.9% | Unkown | |
| HY-400882 | Tosylate-DPA-714 | Ligand | 98.78% | Unkown |
| HY-10219G | Rapamycin (GMP) | / | Unkown | |
| HY-174802 | XL-3158 | Inhibitor | 99.55% | Unkown |
| HY-13912G | IWP-2 (GMP) | Inhibitor | / | Unkown |
| HY-14648G | Dexamethasone (GMP) | Agonist | / | Unkown |
| HY-15147G | XAV-939 (GMP) | Inhibitor | / | Unkown |
| HY-110385A | cGAMP diammonium | Activator | 96.63% | Unkown |
| HY-50723 | 3-Methylxanthine | 99.45% | Unkown | |
| HY-13418G | Dorsomorphin dihydrochloride (GMP) | Inhibitor | / | Unkown |
| HY-112486G | TA-316 (GMP) | Agonist | / | Unkown |
| HY-Y0320GL | Dimethyl sulfoxide (GMP Like) | Inhibitor | 99.99% | Unkown |
| HY-112754AGL | DOTAP chloride (GMP Like) | / | Unkown | |
| HY-15141G | Staurosporine (GMP) | Inhibitor | / | Unkown |
| HY-110397G | KP-457 (GMP) | Inhibitor | / | Unkown |
| HY-50723R | 3-Methylxanthine (Standard) | 99.58% | Unkown | |
| HY-10219GL | Rapamycin (GMP Like) | / | Unkown | |
| HY-13631EG | Deruxtecan (GMP) | / | Unkown | |
| HY-170362A | (R)-cGAS-IN-4 | Control | 99.94% | Unkown |
| HY-P1179A | Guanylin(human) TFA | Activator | 98.54% | Unkown |
| HY-148748G | Butyzamide (GMP) | Activator | / | Unkown |
| HY-107780 | Cyclic-di-GMP | Activator | 98.18% | Unkown |
| HY-12318G | IBMX (GMP) | Inhibitor | / | Unkown |
| HY-15659G | Wnt-C59 (GMP) | Inhibitor | / | Unkown |
| HY-100933 | MY-5445 | Inhibitor | 99.79% | Unkown |
| HY-108548 | Rp-8-Br-PET-cGMPS sodium | Inhibitor | 99.42% | Unkown |
| HY-123468 | HA-1004 | Inhibitor | 99.04% | Unkown |
| HY-P0229A | Ribonuclease T1 (animal free) | / | Unkown | |
| HY-P1179 | Guanylin(human) | Activator | 99.77% | Unkown |
| HY-100564BS | 2',3'-cGAMP-d8 ammonium | 99.90% | Unkown | |
| HY-134541GL | SM-102 (GMP Like) | / | Unkown | |
| HY-N0737AG | Harmine (GMP) | Inhibitor | / | Unkown |
| HY-N5134S2 | 5'-Guanylic acid-15N5 dilithium | 99.33% | Unkown | |
| HY-163668 | MK-2118 | Agonist | / | Unkown |
| HY-113469B | Cyclic GMP TBAOH | / | Unkown | |
| HY-112764GL | DMG-PEG 2000 (GMP Like) | 99.86% | Unkown | |
| HY-119808 | Terrein | 99.44% | Unkown | |
| HY-130530 | AP-C5 | 99.30% | Unkown | |
| HY-17447AG | Tranylcypromine hydrochloride (GMP) | Inhibitor | / | Unkown |
| HY-W000423G | DBCO-amine (GMP) | / | Unkown | |
| HY-W654000 | Cyclic GMP-13C,15N2 | 98.81% | Unkown | |
| HY-15764G | A 419259 (GMP) | / | Unkown | |
| HY-78932G | Dap-NE hydrochloride (GMP) | / | Unkown | |
| HY-10475G | AM580 (GMP) | Agonist | / | Unkown |
| HY-100224G | SANT-1 (GMP) | / | Unkown | |
| HY-100374G | Val-Cit-PAB-MMAE (GMP) | / | Unkown | |
| HY-10181G | Dasatinib (GMP) | / | Unkown | |
| HY-114548 | Ebselen oxide | Inhibitor | 98.0% | Unkown |
| HY-115745 | Calmodulin antagonist-1 | Antagonist | 98.0% | Unkown |
| HY-119611A | Thioquinapiperifil dihydrochloride | Inhibitor | 99.22% | Unkown |
| HY-119819 | Psicofuranine | Inhibitor | 98.0% | Unkown |
| HY-134541G | SM-102 (GMP) | / | Unkown | |
| HY-134919 | CU-76 | Inhibitor | 97.6% | Unkown |
| HY-13506G | M344 (GMP) | Inhibitor | / | Unkown |
| HY-135110 | Rp-8-Br-cGMPS sodium | 99.9% | Unkown | |
| HY-15682G | TTNPB (GMP) | Agonist | / | Unkown |
| HY-78738G | MC-Val-Cit-PAB (GMP) | / | Unkown | |
| HY-78921AG | Fmoc-3VVD-OH (GMP) | / | Unkown | |
| HY-B0185G | Lidocaine (GMP) | / | Unkown | |
| HY-W767865 | Cyclic GMP sodium-13C5 | 99.03% | Unkown | |
| HY-Y0850AGL2 | Polyvinyl alcohol, MW 64000 (GMP Like) | / | Unkown | |
| HY-178589 | Biotin-7-GMP | / | Unkown | |
| HY-W507009 | L-Arginyl-L-alanine | 99.75% | Unkown | |
| HY-10182C | Laduviglusib dihydrochloride | / | Unkown | |
| HY-15371G | Forskolin (GMP) | / | Unkown | |
| HY-15582G | Auristatin E (GMP) | Inhibitor | / | Unkown |
| HY-78931G | Boc-Dap-NE (GMP) | / | Unkown | |
| HY-10407G | SU 5402 (GMP) | Inhibitor | / | Unkown |
| HY-12186G | 3-Deazaneplanocin A hydrochloride (GMP) | Inhibitor | / | Unkown |
| HY-12323G | ISX-9 (GMP) | Activator | / | Unkown |
| HY-13319G | JNK-IN-8 (GMP) | Inhibitor | / | Unkown |
| HY-13526G | YO-01027 (GMP) | Inhibitor | / | Unkown |
| HY-14398GL | Celecoxib (GMP Like) | Inhibitor | / | Unkown |
| HY-15578G | McMMAF (GMP) | / | Unkown | |
| HY-15579BG | MMAF sodium (GMP) | Inhibitor | / | Unkown |
| HY-15579G | MMAF (GMP) | Inhibitor | / | Unkown |
| HY-16700G | PNU-159682 (GMP) | Inhibitor | / | Unkown |
| HY-184095 | Iptocigistat | Inhibitor | / | Unkown |
| HY-50751G | Linifanib (GMP) | Inhibitor | / | Unkown |
| HY-U00449G | AGN 193109 (GMP) | Antagonist | / | Unkown |
| HY-100596G | AS1842856 (GMP) | Inducer | / | Unkown |
| HY-101445G | Trolox (GMP) | / | Unkown | |
| HY-101570G | Nedisertib (GMP) | Inhibitor | / | Unkown |
| HY-10181GL | Dasatinib (GMP Like) | / | Unkown | |
| HY-10221G | Vorinostat (GMP) | Inhibitor | / | Unkown |
| HY-10227G | Bortezomib (GMP) | / | Unkown | |
| HY-10320G | Doramapimod (GMP) | Inhibitor | / | Unkown |
| HY-10321G | PD173074 (GMP) | Inhibitor | / | Unkown |
| HY-10585AG | Valproic acid sodium (GMP) | / | Unkown | |
| HY-106110 | OP-2507 | / | Unkown | |
| HY-106235 | LB80317 | Inhibitor | / | Unkown |
| HY-107413G | SR11237 (GMP) | / | Unkown | |
| HY-107614G | 1-Oleoyl lysophosphatidic acid sodium (GMP) | Activator | / | Unkown |
| HY-10966G | SB-590885 (GMP) | Inhibitor | / | Unkown |
| HY-110382S | Cyclic-di-GMP-13C20,15N10 disodium | Activator | / | Unkown |
| HY-111783G | AZD-7648 (GMP) | / | Unkown | |
| HY-112005G | DOPE (GMP) | Inhibitor | / | Unkown |
| HY-112005GL | DOPE (GMP Like) | / | Unkown | |
| HY-112251GL | D-Lin-MC3-DMA (GMP Like) | / | Unkown | |
| HY-112348 | HA-1004 hydrochloride | Inhibitor | / | Unkown |
| HY-119611 | Thioquinapiperifil | Inhibitor | / | Unkown |
| HY-12041G | SP600125 (GMP) | / | Unkown | |
| HY-12238G | IWR-1 (GMP) | Inhibitor | / | Unkown |
| HY-12278G | K02288 (GMP) | Inhibitor | / | Unkown |
| HY-12292G | IM-12 (GMP) | / | Unkown | |
| HY-12299G | WH-4-023 (GMP) | Inhibitor | / | Unkown |
| HY-12305G | Q-VD-OPh (GMP) | Inhibitor | / | Unkown |
| HY-12362G | Val-cit-PAB-OH (GMP) | / | Unkown | |
| HY-12519G | Oltipraz (GMP) | / | Unkown | |
| HY-126675G | AS2863619 (GMP) | / | Unkown | |
| HY-12879G | IWP-4 (GMP) | Inhibitor | / | Unkown |
| HY-128952G | Tesirine (GMP) | / | Unkown | |
| HY-129670 | KMUP-1 | / | Unkown | |
| HY-13067G | Celastrol (GMP) | / | Unkown | |
| HY-131817 | 5'-GMPS | / | Unkown | |
| HY-131833G | Fmoc-Gly-Gly-Phe-OH (GMP) | / | Unkown | |
| HY-131990G | MC-Gly-Gly-Phe-Gly-NH-CH2-O-CH2COOH (GMP) | / | Unkown | |
| HY-13227G | SD-208 (GMP) | Inhibitor | / | Unkown |
| HY-13259G | MG-132 (GMP) | / | Unkown | |
| HY-13271AG | Tubastatin A (GMP) | / | Unkown | |
| HY-134242 | 6-T-5'-GMP disodium | / | Unkown | |
| HY-134242A | 6-T-5'-GMP | / | Unkown | |
| HY-13441G | (-)-Blebbistatin (GMP) | Inhibitor | / | Unkown |
| HY-135146G | GSK-3484862 (GMP) | / | Unkown | |
| HY-13642G | RG108 (GMP) | Inhibitor | / | Unkown |
| HY-13689G | Go 6983 (GMP) | / | Unkown | |
| HY-137662A | 5'-Phosphoguanylyl-(3',5')-guanosine trisodium | Control | / | Unkown |
| HY-138300GL | ALC-0159 (GMP Like) | / | Unkown | |
| HY-138794G | XL177A (GMP) | Inhibitor | / | Unkown |
| HY-13990G | NVP-TNKS656 (GMP) | / | Unkown | |
| HY-141520G | ART558 (GMP) | Inhibitor | / | Unkown |
| HY-14176G | Compound E (GMP) | Inhibitor | / | Unkown |
| HY-14397G | Indomethacin (GMP) | Inhibitor | / | Unkown |
| HY-14398G | Celecoxib (GMP) | Inhibitor | / | Unkown |
| HY-145973AGL | 3'OMe-m7GpppAmpG ammonium solution (100 mM) (GMP Like) | Inhibitor | / | Unkown |
| HY-145974AGL | m7GpppAmpG ammonium solution (100 mM) (GMP like) | / | Unkown | |
| HY-14823G | Sobetirome (GMP) | Agonist | / | Unkown |
| HY-15149G | Romidepsin (GMP) | / | Unkown | |
| HY-15150G | Bemcentinib (GMP) | Inhibitor | / | Unkown |
| HY-15244G | Alpelisib (GMP) | / | Unkown | |
| HY-153209G | Adjuvant-4 (GMP) | / | Unkown | |
| HY-155337 | eIF4E-IN-6 | Inhibitor | / | Unkown |
| HY-156087 | Cholicamideβ | Inducer | / | Unkown |
| HY-156087G | Cholicamideβ (GMP) | Inducer | / | Unkown |
| HY-15794G | Nemorubicin (GMP) | / | Unkown | |
| HY-15825G | IWP L6 (GMP) | Inhibitor | / | Unkown |
| HY-15893G | DMOG (GMP) | / | Unkown | |
| HY-15947G | Ravoxertinib (GMP) | Inhibitor | / | Unkown |
| HY-159642G | Dabogratinib (GMP) | Inhibitor | / | Unkown |
| HY-162459 | cGAS-IN-3 | Inhibitor | / | Unkown |
| HY-16294G | LY2090314 (GMP) | Inhibitor | / | Unkown |
| HY-16561G | Resveratrol (GMP) | / | Unkown | |
| HY-16658BG | Z-VAD-FMK (GMP) | Inhibitor | / | Unkown |
| HY-16900G | Rolipram (GMP) | Inhibitor | / | Unkown |
| HY-16910G | WIKI4 (GMP) | / | Unkown | |
| HY-171561G | DOTAM-Maleimide triTFA (GMP) | / | Unkown | |
| HY-172533 | 3′,5′-DiOA-dC | Agonist | / | Unkown |
| HY-17356G | Fenofibrate (GMP) | / | Unkown | |
| HY-179624 | cGAS-IN-7 | Inhibitor | / | Unkown |
| HY-180211 | cGAS-IN-8 | Inhibitor | / | Unkown |
| HY-18733G | Lipoic acid (GMP) | / | Unkown | |
| HY-18740 | Trequinsin | Inhibitor | / | Unkown |
| HY-18964G | MG-101 (GMP) | / | Unkown | |
| HY-18985G | Phorbol 12,13-dibutyrate (GMP) | Activator | / | Unkown |
| HY-19318G | Fmoc-Val-Cit-PAB (GMP) | / | Unkown | |
| HY-20336G | Mc-Val-Cit-PABC-PNP (GMP) | / | Unkown | |
| HY-20457G | TL8-506 (GMP) | / | Unkown | |
| HY-42360G | SMCC (GMP) | / | Unkown | |
| HY-42972G | DBCO-acid (GMP) | / | Unkown | |
| HY-44980G | Fmoc-Gly-NH-CH2-acetyloxy (GMP) | / | Unkown | |
| HY-45672G | Gly-Gly-Phe-Gly-NH-CH2-O-CH2COOH (GMP) | / | Unkown | |
| HY-50698G | BI 2536 (GMP) | / | Unkown | |
| HY-70044G | GSK-1070916 (GMP) | / | Unkown | |
| HY-78736G | Val-Cit-PAB-OSBT (GMP) | / | Unkown | |
| HY-B0150G | Nicotinamide (GMP) | Inhibitor | / | Unkown |
| HY-B0350AG | Sodium butyrate (GMP) | / | Unkown | |
| HY-B0356G | Ciprofloxacin (GMP) | / | Unkown | |
| HY-B0377G | Famotidine (GMP) | Agonist | / | Unkown |
| HY-B0399G | L-Carnitine (GMP) | / | Unkown | |
| HY-B0400CGL | D-Sorbitol, M150 (GMP Like) | / | Unkown | |
| HY-B0400DGL | D-Sorbitol, M200 (GMP Like) | / | Unkown | |
| HY-B0400EGL | D-Sorbitol, M400 (GMP Like) | / | Unkown | |
| HY-B0434G | Ribavirin (GMP) | Inhibitor | / | Unkown |
| HY-B0450AG | Ciclopirox olamine (GMP) | Inhibitor | / | Unkown |
| HY-B0497G | Niclosamide (GMP) | Inhibitor | / | Unkown |
| HY-B1402G | Hydrocortisone hemisuccinate (GMP) | Inhibitor | / | Unkown |
| HY-B1505G | Acefylline (GMP) | / | Unkown | |
| HY-B1511G | Cyclic AMP (GMP) | / | Unkown | |
| HY-B2242GL | Calcium phosphate (GMP Like) | / | Unkown | |
| HY-E70069GL | Endo S2, Streptococcus pyogenes (GMP Like) | / | Unkown | |
| HY-E70441 | Guanosine kinase | / | Unkown | |
| HY-N0083G | Betulin (GMP) | / | Unkown | |
| HY-N0322GL | Cholesterol (GMP Like) | Agonist | / | Unkown |
| HY-N0378AGL | D-Mannitol, M200 (GMP Like) | / | Unkown | |
| HY-N0378BGL | D-Mannitol, M100 (GMP Like) | / | Unkown | |
| HY-N0390G | L-Glutamine (GMP) | Inhibitor | / | Unkown |
| HY-N0565AG | Doxycycline (hydrochloride) (GMP) | / | Unkown | |
| HY-N15159 | Cladophorol A | Inhibitor | / | Unkown |
| HY-N5134S1 | 5'-Guanylic acid-13C10 dilithium | / | Unkown | |
| HY-N5134S3 | 5'-Guanylic acid-d12 dilithium | / | Unkown | |
| HY-P2865 | Guanylate kinase | / | Unkown | |
| HY-P2865A | Guanylate Kinase, Porcine | / | Unkown | |
| HY-P5072 | GRP (14-27) (human, porcine, canine) | Agonist | / | Unkown |
| HY-RS05528 | GMPS Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-W013636AG | 2-Ketoglutaric acid Sodium (GMP) | Inhibitor | / | Unkown |
| HY-W087187G | DOTAGA-anhydride (GMP) | / | Unkown | |
| HY-Y1311G | Malic acid (GMP) | / | Unkown | |
| HY-101085G | SKL2001 (GMP) | Agonist | / | Unkown |
| HY-107632G | GYY4137 (GMP) | / | Unkown | |
| HY-107780A | Cyclic-di-GMP sodium | Activator | / | Unkown |
| HY-111582G | BBIQ (GMP) | Agonist | / | Unkown |
| HY-112582AGL | N1-Methylpseudouridine-5′-triphosphate (GMP like) | / | Unkown | |
| HY-12273G | DMH-1 (GMP) | Inhibitor | / | Unkown |
| HY-12848G | SAG (GMP) | Agonist | / | Unkown |
| HY-131764 | 2'-O-MB-cGMP sodium | Inhibitor | / | Unkown |
| HY-133540G | Maleimide-DOTA (GMP) | / | Unkown | |
| HY-135110A | Rp-8-Br-cGMPS | / | Unkown | |
| HY-138170GL | ALC-0315 (GMP Like) | / | Unkown | |
| HY-141432G | NX-1607 (GMP) | Inhibitor | / | Unkown |
| HY-171020 | 8-Nitro-2'3'cGMP | / | Unkown | |
| HY-171520 | 2'-O-MOE-GMP | / | Unkown | |
| HY-171523 | LNA-GMP | / | Unkown | |
| HY-172512 | 3'-O-Methylguanosine-5'-monophosphate | / | Unkown | |
| HY-178557 | Im-3'-OMe-GMP | / | Unkown | |
| HY-178572 | 3'-OMe-m7GMP | / | Unkown | |
| HY-181713 | Antibiofilm agent-19 | / | Unkown | |
| HY-183863 | N-(4-(1H-Pyrazol-1-yl)butyl)-5-(furan-2-yl)isoxazole-3-carboxamide | / | Unkown | |
| HY-50723S1 | 3-Methylxanthine-d3 | / | Unkown | |
| HY-B0342GL | Meglumine (GMP Like) | / | Unkown | |
| HY-B0764G | Bucladesine sodium (GMP) | Activator | / | Unkown |
| HY-N0391G | L-Citrulline (GMP) | Inhibitor | / | Unkown |
| HY-N0614GL | Sucralose (GMP Like) | / | Unkown | |
| HY-N11522 | 5-Methyluridine 5′-triphosphate | / | Unkown | |
| HY-N15369 | 3′-GMP | / | Unkown | |
| HY-N5134A | ara-GMP | / | Unkown | |
| HY-N5134S4 | 5'-Guanylic acid-15N5,d12 dilithium | / | Unkown | |
| HY-N5134S5 | 5'-Guanylic acid-13C10,15N5 dilithium | / | Unkown | |
| HY-RS20744 | Gmps Mouse Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS27256 | Gmps Rat Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-W011053GL | Neotame (GMP Like) | Inducer | / | Unkown |
| HY-W040193GL | DSPC (GMP Like) | / | Unkown | |
| HY-W1048843AG | 4-Arm PEG5000-NH2 (GMP) | / | Unkown | |
| HY-W1048843AGL | 4-Arm PEG5000-NH2 (GMP Like) | / | Unkown |